Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
2. Cct245737
1. Cct245737
2. 1489389-18-5
3. Cct-245737
4. Qb6lnl4nf6
5. Sra737
6. Sra-737 [who-sdg]
7. Pnt-737
8. Sra-737
9. 2-pyrazinecarbonitrile, 5-((4-(((2r)-2-morpholinylmethyl)amino)-5-(trifluoromethyl)-2-pyridinyl)amino)-
10. Unii-qb6lnl4nf6
11. Gtpl9187
12. Chembl4169078
13. Schembl15392098
14. Us9663503, Compound 1
15. Bdbm328993
16. Sra737; Pnt-737
17. Ex-a1607
18. Mfcd30489721
19. Nsc793726
20. Zinc205442186
21. Ccg-268393
22. Compound 4 [pmid: 27167172]
23. Cs-5863
24. Nsc-793726
25. Cct-245737?
26. Ac-36122
27. Bs-15458
28. Hy-18958
29. J3.603.159j
30. Q27075794
31. (r)5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
32. (r)a?-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
33. 5-[(4-{[(2r)-morpholin-2-ylmethyl]amino}-5-(trifluoromethyl)pyridin-2-yl)amino]pyrazine-2-carbonitrile
34. 5-[[4-[[(2r)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile
35. 5-[[4-[[(2r)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)pyridin-2-yl]amino]pyrazine-2-carbonitrile
| Molecular Weight | 379.34 g/mol |
|---|---|
| Molecular Formula | C16H16F3N7O |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 379.13684265 g/mol |
| Monoisotopic Mass | 379.13684265 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 526 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of SRA737 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right SRA737 manufacturer or SRA737 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred SRA737 manufacturer or SRA737 supplier.
PharmaCompass also assists you with knowing the SRA737 API Price utilized in the formulation of products. SRA737 API Price is not always fixed or binding as the SRA737 Price is obtained through a variety of data sources. The SRA737 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SRA737 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SRA737, including repackagers and relabelers. The FDA regulates SRA737 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SRA737 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SRA737 supplier is an individual or a company that provides SRA737 active pharmaceutical ingredient (API) or SRA737 finished formulations upon request. The SRA737 suppliers may include SRA737 API manufacturers, exporters, distributors and traders.
SRA737 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SRA737 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SRA737 GMP manufacturer or SRA737 GMP API supplier for your needs.
A SRA737 CoA (Certificate of Analysis) is a formal document that attests to SRA737's compliance with SRA737 specifications and serves as a tool for batch-level quality control.
SRA737 CoA mostly includes findings from lab analyses of a specific batch. For each SRA737 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SRA737 may be tested according to a variety of international standards, such as European Pharmacopoeia (SRA737 EP), SRA737 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SRA737 USP).
